Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: A potential novel treatment in a rat model of Huntington's disease

Brain Research

Volumn 787, Issue 1, 1998, Pages 143-148

  Joel, D ^a   Ayalon, L ^a   Tarrasch, R ^a   Veenman, L ^b   Feldon, J ^b   Weiner, I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ETH ZURICH   (Switzerland)

Author keywords

Basal ganglia; Globus Pallidus; Huntington's disease; Lesion; Quinolinic acid; Rat; Striatum; Water maze

Indexed keywords

QUINOLINIC ACID;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; ELECTROLYSIS; GLOBUS PALLIDUS; HUNTINGTON CHOREA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ELECTROLYSIS; GLOBUS PALLIDUS; HUNTINGTON DISEASE; MALE; MAZE LEARNING; MOTOR ACTIVITY; NERVE DEGENERATION; QUINOLINIC ACID; RATS; RATS, WISTAR;

EID: 0032536750     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01428-5     Document Type: Article

References (35)

1. [1] R.L. Albin, A.B. Young, J.B. Penney, The functional anatomy of basal ganglia disorders, Trends Neurosci. 12 (1989) 366-375.
2. [2] J.B. Martin, J.F. Gusella, Huntington's disease: pathogenesis and management, New Engl. J. Med. 315 (1986) 1267-1276.
3. [3] J.B. Penney, A.B. Young, Striatal inhomogeneities and basal ganglia function, Mov. Disord. 1 (1986) 3-15.
4. [4] R.L. Albin, A. Reiner, K.D. Anderson, J.B. Penney, A.B. Young, Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia, Ann. Neurol. 27 (1990) 357-365.
5. [5] R.L. Albin, A.B. Young, J.B. Penney, B. Handelin, K.D. Balfour, D.S. Markel, W.W. Tourtelotte, A. Reiner, Abnormalities of Striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease, New Engl. J. Med. 322 (1990) 1293-1298.
6. [6] R.J. Ferrante, N.W. Kowall, E.O. Richardson, E.D. Bird, J.B. Martin, Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum, Neurosci. Lett. 71 (1985) 283-288.
7. [7] M.R. Hayden, W.R.W. Martin, A.J. Stoessl, C. Clark, S. Hollenberg, M.J. Adam, W. Ammann, R. Harrop, J. Rogers, T. Ruth, C. Sayre, B.D. Pate, Positron emission tomography in the early diagnosis of Huntington's disease, Neurology 36 (1986) 888-894.
8. [8] N.M. Kowall, R.J. Ferrante, J.B. Martin, Patterns of cell loss in Huntington's disease, Trends Neurosci. 10 (1987) 24-29.
9. [9] A. Reiner, R.L. Albin, K.D. Anderson, C.J. D'Amato, J.B. Penney, A.B. Young, Differential loss of striatal projection neurons in Huntington's disease, Proc. Natl. Acad. Sci. U.S.A. 64 (1988) 397-404.
10. [10] E. Sapp, P. Ge, H. Aizawa, E. Bird, J. Penney, A.B. Young, J.-P. Vonsattel, M. DiFiglia, Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis, Neuroscience 64 (1995) 397-404.
11. [11] J.-P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, P.A. Paskevich, E.P. Richardson, E.D. Bird, Huntington's disease: neuropathological grading, in: M.B. Carpenter, A. Jayaraman (Eds.), The Basal Ganglia II: Structure and Function - Current Concepts, Plenum, New York, 1987, pp. 515-531.
12. [12] C.M. Waters, R. Peck, M. Rossor, G.P. Reynolds, S.P. Hunt, Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea, Neuroscience 25 (1988) 419-438.
13. [13] A.B. Young, J.B. Penney, S. Starosta-Rubinstein, D.S. Markel, S. Berent, B. Giordani, R. Ehrenkaufer, D. Jewett, R. Hichwa, PET scan investigations of Huntington's disease: cerebellar metabolic correlates of neurological features and functional decline, Ann. Neurol. 20 (1986) 296-303.
14. [14] K.P. Bhatia, C.D. Marsden, The behavioural and motor consequences of focal lesions of the basal ganglia in man, Brain 117 (1994) 859-876.
15. [15] A.R. Crossman, Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders, Neuroscience 21 (1987) 1-40.
16. [16] D. Joel, I. Weiner, The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry, Brain Res. Rev. 111 (1997) 92-103.
17. [17] M. DiFiglia, Excitotoxic injury of the neostriatum: a model for Huntington's disease, Trends Neurosci. 13 (1990) 286-289.
18. [18] D.F. Emerich, P.R. Sanberg, Animal models of Huntington's disease, in: A.A. Boulton, G.B. Baker, R.F. Butterworth (Eds.), Neuromethods 21 - Neurodegenerative diseases, Humana Press, NJ, 1992, pp. 65-134.
19. [19] R.J. Ferrante, M.F. Beal, N.W. Kowall, Mechanisms of neural degeneration in Huntington's disease. in: G. Percheron, J.S. McKenzie, J. Feger (Eds.), The Basal Ganglia IV: New Ideas and Data on Structure and Function, Plenum, New York, 1994, pp. 149-161.
20. [20] M.F. Beal, N.W. Kowall, D.W. Ellison, M.F. Mazurek, K.J. Swartz, J.B. Martin, Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid, Nature 321 (1986) 168-171.
21. [21] D.W. Ellison, M.F. Beal, M.F. Mazurek, J.R. Malloy, E.D. Bird, J.B. Martin, Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease, Brain 110 (1987) 1657-1673.
22. [22] R.C. Roberts, A. Ahn, K.J. Swartz, M.F. Beal, M. DiFiglia, Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome, Exp. Neurol. 124 (1993) 274-282.
23. [23] R.C. Roberts, M. DiFiglia, Short-and long-term survival of large neurons in the excitoxic lesioned rat caudate nucleus: a light and electron microscopic study, Synapse 3 (1989) 363-371.
24. [24] K.D. Figueredo-Cardenas, K.D. Anderson, Q. Chen, C.L. Veenman, A. Reiner, Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats, Exp. Neurol. 129 (1994) 37-56.
25. [25] J.C.S. Furtado, M.F. Mazurek, Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease, Exp. Neurol. 138 (1996) 158-168.
26. [26] P.R. Sanberg, S.F. Calderon, M. Giordano, J.M. Tew, A.B. Norman, The quinolinic acid model of Huntington's disease: locomotor abnormalities, Exp. Neurol. 105 (1989) 45-53.
27. [27] K.C. Berridge, H.C. Cromwell, Motivational-sensorimotor interaction controls aphagia and exaggerated treading after striatopallidal lesions, Behav. Neurosci. 104 (1990) 778-795.
28. [28] G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego, 1986.
29. [29] H.C. Cromwell, K.C. Berridge, Implementation of action of sequences by a neostriatal site: a lesion mapping study of grooming syntax, J. Neurosci. 16 (1996) 3444-3458.
30. [30] F. Block, M. Kunkel, M. Schwarz, Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats, Neurosci. Lett. 149 (1993) 126-128.
31. [31] I.Q. Whishaw, G. Mittleman, S.T. Bunch, S.B. Dunnet, Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesion in rats, Behav. Brain Res. 24 (1987) 125-138.
32. [32] W. Hauber, W.J. Schmidt, Differential effects of lesions of the dorsomedial and dorsolateral caudate-putamen on reaction time performance in rats, Behav. Brain Res. 60 (1994) 211-215.
33. [33] C.D. Marsden, J.A. Obeso, The functions of the basal ganglia and the paradox of Stereotaxic surgery in Parkinson's disease, Brain 117 (1994) 877-897.
34. [34] H. Aizawa, S. Kwak, T. Shimizu, J. Goto, I. Nakano, T. Mannen, H. Shibasaki, A case of adult onset pure pallidal degeneration: I. Clinical manifestations and neuropathological observations, J. Neurol. Sci. 102 (1991) 76-82.
35. [35] D.R. Weinberger, K.F. Berman, M. Iadarola, N. Driesen, R. Zec, Prefrontal cortical blood flow and cognitive function in Huntington's disease, J. Neurol. Neurosurg. Psychiatry 52 (1988) 94-104.